Related Experiment Video
Updated: May 24, 2026

Assessing Signaling Properties of Ectodermal Epithelia During Craniofacial Development
Published on: March 24, 2011
Neural crest cells pattern the surface cephalic ectoderm during FEZ formation
1Department of Orthopaedic Surgery, San Francisco General Hospital, The University of California San Francisco, School of Medicine, San Francisco, California 94110, USA.
Background:
Multiple fibroblast growth factor (Fgf) ligands are expressed in the forebrain and facial ectoderm, and vascular endothelial growth factor (VEGF) is expressed in the facial ectoderm. Both pathways activate the MAP kinase cascade and can be suppressed by SU5402. We placed a bead soaked in SU5402 into the brain after emigration of neural crest cells was complete.
Results:
Within 24 hr we observed reduced pMEK and pERK staining that persisted for at least 48 hr. This was accompanied by significant apoptosis in the face. By day 15, the upper beaks were truncated. Molecular changes in the FNP were also apparent. Normally, Shh is expressed in the frontonasal ectodermal zone and controls patterned growth of the upper jaw. In treated embryos, Shh expression was reduced. Both the structural and molecular deficits were mitigated after transplantation of FNP-derived mesenchymal cells.
Conclusions:
Thus, mesenchymal cells actively participate in signaling interactions of the face, and the absence of neural crest cells in neurocristopathies may not be merely structural.
Insights
Fibroblast growth factor (Fgf) and vascular endothelial growth factor (VEGF) signaling are crucial for facial development. Inhibiting these pathways with SU5402 caused facial apoptosis and truncation, but mesenchymal cell transplantation restored normal development.
Area of Science:
- Developmental biology
- Molecular biology
- Craniofacial development
Background:
- Fibroblast growth factor (Fgf) and vascular endothelial growth factor (VEGF) are expressed in the developing face.
- Both pathways activate the MAP kinase cascade.
- SU5402 inhibits these signaling pathways.
Purpose of the Study:
- To investigate the role of Fgf and VEGF signaling in craniofacial development.
- To examine the effects of SU5402 inhibition on facial development.
- To determine the contribution of mesenchymal cells to facial signaling.
Main Methods:
- Administration of SU5402-soaked beads into the embryonic brain after neural crest cell emigration.
- Analysis of pMEK and pERK staining to assess MAP kinase pathway activation.
- Assessment of apoptosis, facial morphology, and gene expression (Shh).
- Transplantation of frontonasal prominence (FNP)-derived mesenchymal cells.
Main Results:
- SU5402 treatment led to reduced pMEK and pERK staining, indicating pathway inhibition.
- Significant facial apoptosis and truncated upper beaks were observed.
- Shh expression in the frontonasal ectodermal zone was reduced.
- Transplantation of mesenchymal cells mitigated the structural and molecular deficits.
Conclusions:
- Mesenchymal cells play an active role in facial signaling interactions.
- Deficits in neurocristopathies may involve more than just structural absence of neural crest cells.
Related Concept Videos
Neurulation
Determination
Gastrulation
Zygotic Development And Stem Cell Formation
Cleavage and Blastulation

